Related by context. All words. (Click for frequent words.) 71 Crohn Disease Activity 70 Disease Activity 69 BILAG 69 Score DAS 68 Visual Analogue Scale VAS 67 DAS# [002] 66 Brief Psychiatric 66 DAS# CRP 65 NIH CPSI 65 EQ 5D 65 serologically active patients 64 Global Impression CGI 64 Health Assessment Questionnaire 64 PANSS 64 Psoriasis Area 63 HAQ DI 63 CDAI score 63 PCWP 63 Severity Index PASI 63 Index CDAI 63 ADAS cog 63 Rating Scale BPRS 63 WOMAC pain 62 serum HBV DNA 62 symptom severity 62 demonstrated clinically meaningful 62 CFQ R 62 YMRS 62 WOMAC 61 multivariate Cox 61 ADCS CGIC 61 UPDRS 61 CDAI 61 Scale PANSS 61 HRQoL 61 Functional Assessment 61 BMI z 61 Neuropsychiatric Inventory NPI 61 NIHSS 61 IBDQ 61 interobserver 60 Cystic Fibrosis Questionnaire Revised 60 SLEDAI 60 Status Scale EDSS 60 DAS# scores 60 Primary endpoints 60 platelet reactivity 60 erythrocyte sedimentation rate 60 semiquantitative 60 HAMD 60 subscore 60 ADCS ADL 60 AST ALT 60 SGRQ 60 autoantibody levels 60 HOMA IR 60 Fibromyalgia Impact Questionnaire 60 PSA nadir 60 HAM D# 60 subscores 60 serum urate 60 Scale EDSS 60 SSc 60 QIDS SR 60 induration 60 Score TOS 59 Histologic 59 ADAS Cog 59 EORTC QLQ C# 59 PASI scores 59 Ocular Surface Disease 59 nasal symptom 59 IPSS 59 antibody titer 59 intratumoral 59 HER2 overexpression 59 Rating Scale UPDRS 59 QoL 59 function subscale 59 Montgomery Asberg Depression 59 PANSS total 59 Alzheimer Disease Assessment 59 hematologic parameters 59 bronchial hyperresponsiveness 59 Visual Analog Scale 59 symptomatic VTE 59 Main Outcome Measure 59 Severity MSCS score 59 T2DM 59 alanine aminotransferase ALT 59 endometrial thickness 59 erection hardness 59 Inventory BPI 59 Cardiotoxicity 59 colorectal adenoma 59 ALSFRS R 59 ANCOVA 59 aminotransferases 59 Negative Syndrome 59 IgG antibody 59 convergent validity 59 Expanded Disability Status 59 CORE OM 59 UPDRS motor 58 non menstrual pelvic 58 Viral load 58 lactate dehydrogenase 58 Unified Parkinson Disease 58 HADS 58 Index CDAI score 58 etiologic 58 pain subscale 58 tipranavir r 58 IRLS 58 PSADT 58 airway hyperresponsiveness 58 HRQL 58 leukocyte counts 58 Montgomery Åsberg Depression 58 clinically meaningful reductions 58 Secondary endpoints included 58 logistic regression analysis 58 Comorbidity 58 glycosylated hemoglobin HbA1c 58 Brief Pain 58 serum ALT 58 MADRS score 58 MADRS 58 Score DAS# 58 Scale cognitive subscale 58 ispinesib administered 58 left ventricular diastolic 58 immunostaining 58 SF #v# 58 Visual Analog 58 alanine aminotransferase 58 peri procedural 58 Outcome Measures 58 hematological parameters 58 glycated hemoglobin levels 58 histologic 58 node metastases 58 Ashworth Scale 58 CCyR 58 serum aminotransferase levels 58 IntroductionThe 58 albumin excretion rate 58 aspartate aminotransferase AST 58 concomitant medications 58 Symptom severity 58 radical prostatectomy RP 58 aminotransferase ALT 58 serum phosphate 58 NIS LL 58 HRQOL 58 visceral adiposity 58 dyssynchrony 58 left ventricular LV 58 ACR# response 58 multivariable adjusted 58 cTnT levels 57 sustained virological response 57 univariate 57 posttransplant 57 enthesitis 57 SCr 57 Endothelial dysfunction 57 rheumatoid factor 57 preoperative PSA 57 eNO 57 multivariable Cox 57 chemosensitivity 57 serum urate levels 57 clinicopathological 57 Scale Cognitive Subscale 57 baseline LDH 57 enzyme immunoassay EIA 57 Main Outcome Measures 57 Skin sterol 57 Score IPSS 57 enterococcal 57 ALS Functional 57 hepatic lesions 57 Symptom Checklist 57 Chronic Illness Therapy 57 insulin resistance HOMA IR 57 International Prognostic Scoring 57 APACHE II 57 FACIT Fatigue 57 pulmonary exacerbations 57 tumor necrosis 57 International Prostate Symptom 57 Distress Scale 57 neutropaenia 57 relapsed MM 57 RECIST Response Evaluation Criteria 57 transaminases 57 Scale EDSS score 57 induced sputum 57 WOMAC TM 57 postoperative AF 57 HBeAg seroconversion 57 subscale scores 57 cognitive affective 57 aspartate aminotransferase 57 NYHA functional class 57 logistic regression model 57 mean ± SEM 57 Tasigna prolongs 57 -#.# log# 57 TURBT 57 intact parathyroid hormone 57 HAM D 57 haematologic 57 antigen PSA levels 57 serum potassium 57 SGOT 57 Abnormal Involuntary Movement 57 lactate dehydrogenase LDH 57 Rating Scale MADRS 57 diabetes mellitus DM 57 confidence intervals CIs 57 Glomerular filtration rate 57 viral tropism 56 transcranial Doppler ultrasound 56 symptomatic intracranial 56 c reactive protein 56 IRLS score 56 NMIBC 56 Cronbach alpha 56 Response Evaluation Criteria 56 confirmed CCyR 56 Prognostic 56 serum PTH 56 mRS 56 FDG uptake 56 subscales 56 F FDG PET 56 FOLFOX6 56 T1a 56 Erectile Function IIEF 56 interferon γ 56 HER2 expression 56 DLQI 56 highest tertile 56 Hematologic toxicity 56 Neuropsychiatric Inventory 56 Cardiorespiratory fitness 56 nonfatal MI 56 UPDRS scores 56 electrophysiologic 56 Dyspnea 56 psychosocial variables 56 depressive symptom 56 Natalizumab 56 atherothrombotic 56 pressure natriuresis 56 sUA 56 liver histology 56 Likert pain 56 Y BOCS 56 urine albumin 56 Ejection Fraction 56 intraobserver 56 serum cortisol 56 HDRS 56 Seattle Angina Questionnaire 56 corticosteroid dose 56 Histopathologic 56 plasma cortisol 56 atheroma volume 56 Kinoid 56 fibrosis progression 56 logistic regression analyzes 56 Physical Component 56 postop 56 gastric cardia 56 MCyR 56 tracer uptake 56 Severity Index 56 Secondary endpoints include 56 pelvic lymphadenectomy 56 lymph node metastasis 56 OSDI 56 hyperhomocysteinemia 56 Erectile Function 56 Mean Symptom Complex 56 viral titers 56 adenoma recurrence 56 HbA 1c levels 56 Univariate 56 pharmacodynamic PD 56 -5 -6 56 System IPSS 56 WOMAC scores 56 Functioning GAF 56 serum IgG 56 IL 1ß 56 lumbar spine BMD 56 arterial oxygen saturation 56 prostate cancer PCa 56 conditional logistic regression 56 IOP lowering 56 HbA 1C 56 mTSS 56 mg TID 56 TIMP 1 56 UPDRS Part III 56 multivariable analysis 56 â ‰ ¥ 56 DAS# remission 56 estimated glomerular filtration 56 Respiratory Symptoms 56 HIV RNA 56 abdominal adiposity 56 p# antigen 56 serum PSA 56 Major Adverse Cardiac 56 macroalbuminuria 56 Secondary efficacy endpoints 56 dactylitis 56 tissue oxygenation 56 interrater reliability 56 fasting insulin 56 BPH symptom 56 nephrotoxicity 56 primary hyperparathyroidism 56 atherothrombotic disease 55 elevated creatinine 55 Negative Symptoms 55 neutrophil counts 55 hip BMD 55 lowest tertile 55 PSQI 55 hematological relapse 55 clinically meaningful improvements 55 inducible nitric oxide synthase 55 tic severity 55 serum homocysteine 55 tamoxifen Nolvadex ® 55 periprocedural 55 pT3 55 serum phosphorous 55 carotid IMT 55 intima media thickness 55 QTcF 55 CR nPR 55 microvessel density 55 scintigraphic 55 gastroduodenal 55 intravascular hemolysis 55 Lp PLA 2 55 myeloperoxidase 55 bivariate 55 = #.#-#.# 55 Evaluable 55 tertiles 55 depressive symptomatology 55 logistic regression models 55 FDG-PET/CT 55 endothelial activation 55 progression TTP 55 hemoglobin A1c levels 55 PSA kinetics 55 HbA 1c 55 PsA 55 glycosylated hemoglobin levels 55 BILAG B 55 sulfasalazine 55 intima media thickness IMT 55 EDSS 55 Kaplan Meier estimates 55 Subgroup analyzes 55 HIV HCV coinfected 55 aPTT 55 sensitivity specificity 55 endoscopic remission 55 pT2 55 odds ratios ORs 55 Retreatment 55 Oswestry Disability Index 55 CC genotype 55 EDSS score 55 retinal thickness 55 urinary albumin 55 STRIDE PD 55 renal cysts 55 postoperative mortality 55 gastric adenocarcinoma 55 Erythropoietic therapies may 55 carotid intima media 55 % CI #.#-#.# [008] 55 artery elasticity 55 Immunohistochemical staining 55 exhaled NO 55 ug dose 55 Geriatric Depression 55 CIMZIA TM certolizumab pegol 55 serum BDNF 55 secondary efficacy endpoint 55 Multivariate logistic regression 55 extramedullary 55 hormone receptor negative 55 leucopenia 55 steroid dexamethasone 55 Lymph node 55 % CI #.#-#.# [007] 55 clinicopathological features 55 tumor regressions 55 TNSS 55 histologic subtype 55 glycaemia 55 C Reactive Protein 55 parasitological 55 apolipoprotein B 55 Cardiopulmonary bypass 55 obstructive coronary 55 chronicity 55 recurrent genital herpes 55 hematopoietic cancers 55 creatine kinase MB 55 meta regression 55 Genotypic 55 Clinician Administered PTSD 55 immunohistochemical 55 biochemical relapse 55 troponin T 55 ANOVA 55 tipranavir ritonavir 55 BENICAR 55 Stroke Scale 55 elevated ALT 55 Pharmacodynamic 55 cytologic 55 histopathologic diagnosis 55 BPRS 55 Global Impression 55 isoprostane 55 venous thromboembolic disease 55 mg BID dose 55 glycemic variability 55 #OHD 55 fructosamine 55 plasma HCV RNA 55 CIMZIA ™ 55 A1c levels 55 IIEF 55 extracapsular extension 55 CNS LS 55 serum parathyroid hormone 55 Non inferiority 55 urinary N telopeptide 55 nodal metastasis 55 paricalcitol 55 ligand induced 55 Solid Tumors criteria 55 Multivariable 55 epoetin alpha 55 -#.# ± [002] 55 aminotransferase 55 Cystatin C 55 D dimer 55 FEV ^ sub 55 cerebral ischemic 55 Assessment Scale 55 Global Impression Severity 55 coronary stenosis 54 postprocedure 54 recurrent ischemia 54 oncologic outcomes 54 inotropic 54 intraclass correlation coefficient 54 ritonavir boosted 54 Uncontrolled hypertension 54 affective psychosis 54 FDG PET imaging 54 Hemoglobin A1c 54 genotypic resistance 54 clinically meaningful improvement 54 hepatic cirrhosis 54 biopsy Gleason 54 Histological 54 Pain Intensity 54 LV dysfunction 54 4mg/kg 54 antiretroviral naïve 54 Endothelial function 54 virological response 54 Hb A1C 54 mL/min/#.# m 2 54 Febrile neutropenia 54 transgene expression 54 fasting plasma glucose 54 metaplasia 54 serum bicarbonate 54 Microalbuminuria 54 SUVmax 54 seropositive patients 54 certolizumab 54 HBeAg 54 RNFL 54 logistic regression 54 Intraocular pressure 54 cTnI 54 subclinical atherosclerosis 54 surgical debulking 54 Mantel Haenszel 54 multivariate analyzes 54 contrast echocardiography 54 CIN3 54 Ischemic 54 plasma viremia 54 #dhTxB# 54 hepatic fibrosis 54 Haptoglobin 54 stratifying patients 54 plus methotrexate 54 virologic responses 54 tertile 54 CIN2 + 54 achieved statistical significance 54 hyperinsulinemic euglycemic clamp 54 Ala Ala 54 lumbar disk herniation 54 p = NS 54 Intraocular Pressure 54 IU ml 54 CIBIC + 54 clinicopathologic 54 CD4 lymphocyte count 54 Univariate analysis 54 univariate analysis 54 demyelinating 54 Secondary endpoints 54 histological subtype 54 moderate renal impairment 54 bioavailable testosterone 54 SGPT 54 nitrotyrosine 54 clinico pathological 54 abdominal pain abdominal discomfort 54 Acute Physiology 54 urine NGAL 54 bronchoalveolar lavage 54 hyperalgesia 54 prospectively stratified 54 log# copies mL 54 CIBIC plus 54 baseline FEV 54 Poisson regression 54 lopinavir r arm 54 urothelial carcinoma 54 generalized estimating 54 Helicobacter pylori eradication 54 aminotransferase levels 54 transaminase 54 antithymocyte globulin 54 pulmonary dysfunction 54 locoregional disease 54 postoperative pulmonary 54 rhinoconjunctivitis 54 plasma renin activity 54 β blockers 54 ABL1 54 multiple linear regression 54 esophageal carcinoma 54 Solid Tumors 54 Visual Analogue Scale 54 RAPAFLO R 54 Hematologic 54 TPV r 54 CHADS2 54 androgen deprivation 54 morphometric vertebral fractures 54 p = #.# [003] 54 carotid artery intima media 54 pretest probability 54 serum magnesium 54 Bonferroni correction 54 pharmacodynamic endpoints 54 interleukin IL -6 54 immunohistochemical staining 54 % CI #.#-#.# [004] 54 Angiotensin converting enzyme 54 euthymic patients 54 multivariate logistic regression 54 independent prognostic marker 54 plasma lipoprotein 54 specific antigen PSA 54 RT qPCR 54 multivariable logistic regression 54 albumin excretion 54 receptor antagonism 54 gadolinium enhancing 54 coagulation abnormalities 54 baseline A1C 54 squamous intraepithelial lesions 54 ARB telmisartan 54 NNT = 54 Index WOMAC 54 CI -#.# 54 Hypertrophy 54 echocardiographic parameters 54 ADHD Rating Scale 54 recurrent venous thromboembolism 54 seropositivity 54 neovascular 54 neurocognitive function 54 lupus anticoagulant 54 mg QD 54 p tau 54 Injury Severity Score 54 multivariable 54 nonfatal myocardial infarction 54 plasma lipid 54 Bioavailability 54 cobiprostone 54 achieved ACR# 54 Erythema 54 Kruskal Wallis test 54 AUA Symptom Score 54 MoxDuo TM IR 54 hepatic enzyme 54 hsCRP 54 methotrexate monotherapy 54 microalbumin 54 tolterodine ER 54 VFQ 54 hemodynamic measurements 54 waist girth 54 elevated transaminases 54 calculated creatinine clearance 54 seminal vesicle invasion 54 infliximab etanercept 54 quasispecies 54 death reinfarction 54 sUA levels 54 APTIVUS r 54 intestinal mucosal 54 symptomatic intracranial hemorrhage 53 atherogenic dyslipidemia 53 axial length 53 % Confidence Interval 53 LV ejection fraction 53 serum bilirubin 53 prospectively defined 53 serum ferritin 53 iPTH 53 interrater 53 prespecified secondary 53 apo B 53 psychopathological symptoms 53 TMC# r 53 urodynamic parameters 53 ALT AST 53 serological markers 53 fasting plasma glucose FPG 53 residual platelet reactivity 53 nondiabetic patients 53 myocardial reperfusion 53 LRP5 53 haematological toxicity 53 PLMs 53 IIIb 53 fludarabine cyclophosphamide 53 biochemical recurrence 53 evaluating tivozanib 53 virus HBV 53 PREZISTA r arm 53 varices 53 mRNA expression 53 x ULN 53 Linear regression 53 pyrazinamide 53 endometrial carcinoma 53 elevated IOP 53 Hemodynamic 53 CIMZIA TM 53 systolic diastolic 53 radiotherapy RT 53 serum IGF 53 immunoreactivity 53 Dysregulation 53 HbA1C levels 53 mucosal healing 53 overt nephropathy 53 Mutational 53 airway responsiveness 53 prostate cancer CaP 53 TNF receptor 53 Rating Scale IRLS 53 canakinumab 53 thyroglobulin 53 Outcomes Study 53 morbidity mortality 53 anthropometric measures 53 nicardipine 53 Kaplan Meier survival 53 ‰ ¥ 53 -#.# log# copies mL 53 rosuvastatin #mg 53 aortic regurgitation 53 androgen suppression 53 neuritic 53 comorbid anxiety 53 serum testosterone 53 nerve conduction velocity 53 cardio respiratory fitness 53 MMSE 53 activated partial thromboplastin 53 surgically resected 53 Kaplan Meier 53 allele frequencies 53 BENICAR HCT 53 desvenlafaxine succinate 53 covariance 53 psychometric properties 53 xenograft models 53 virologic response 53 CP CPPS 53 SELENA SLEDAI score 53 MDRD 53 serum biomarkers 53 pCR 53 percutaneous vertebroplasty 53 hemorrhagic complications 53 PHQ 9 53 estimated GFR 53 renal allograft 53 metastatic neuroendocrine tumors 53 fasting plasma 53 XIENCE V PROMUS Stent 53 scores TNSS 53 pretransplant 53 diabetes dyslipidemia 53 urate lowering therapy 53 salmeterol fluticasone propionate 53 axillary lymph node 53 unfractionated heparin UFH 53 preoperative diagnosis 53 morphologic characteristics 53 Pearson correlation coefficient 53 inflammatory biomarkers 53 Hamilton Rating Scale 53 tumor histology 53 coagulopathy 53 MetS 53 dose atorvastatin 53 Genant modified Sharp 53 hepatic insulin sensitivity 53 acute gout 53 binary restenosis 53 femoral neck BMD 53 ascending aortic 53 immunohistochemical analysis 53 postoperative complication 53 timepoints 53 foveal thickness 53 soluble CD# ligand 53 #F FDG PET 53 thyroid carcinoma 53 radiographic progression 53 Tumor Response 53 liver enzymes ALT 53 piperacillin tazobactam 53 NSTE ACS 53 postural sway 53 mammographic density 53 hematologic toxicity 53 pretreatment serum 53 complete cytogenetic response 53 posttreatment 53 neutropenia febrile neutropenia 53 hepatic enzymes 53 Elastography 53 thromboembolic complications 53 plasma triglycerides 53 Subscale 53 hsCRP levels 53 thyrotropin levels 53 HRCT 53 subthreshold depression 53 HSCT 53 akinesia 53 ecchymosis 53 SLNB 53 plasma leptin 53 sputum eosinophils 53 Virologic 53 serum folate concentrations 53 Depressive Symptoms 53 covariate 53 dyslipidaemia 53 N telopeptide 53 Decitabine 53 ACR# responses 53 arterial elasticity 53 serum concentrations 53 prespecified 53 GSTP1 53 detectable HCV RNA 53 serologically active SLE 53 Kaplan Meier analysis 53 eosinophilia 53 Glomerular Filtration Rate 53 pulmonary arterial 53 Female Sexual Function 53 multiple logistic regression 53 antiandrogens 53 vasomotor 53 undetectable HBV DNA 53 myocardial infarction stroke 53 Ki# 53 metachronous 53 tumor xenograft models 53 waist circumference WC 53 nonpharmacologic 53 intraclass correlation coefficients 53 annualized relapse 53 Beck Anxiety Inventory 53 kidney allograft 53 immunoreactive 53 FluCAM arm 53 combination antiretroviral therapy 53 fibrin deposition 53 Radiographic 53 corneal staining 53 cardiometabolic syndrome 53 PANSS Positive 53 microsatellite instability 53 Diastolic 53 Physical Function 53 Subgroup analysis 53 % CI #.#-#.# [005] 53 leukocytosis 53 Pegasys ® 53 -#.# mg dL [001] 53 Fractional Flow Reserve 53 salmeterol fluticasone 53 liver metastasis 53 predictive biomarker 53 allostatic load 53 epididymal 53 NPRS 53 apolipoprotein A1 53 lymphocyte count 53 CK MB 53 multivariate regression analysis 53 PKC inhibitors 53 μg liter 53 syndromic 53 binary logistic regression 53 BEXXAR Therapeutic Regimen 53 metabolic syndrome MetS 53 antibody mediated 53 urinary excretion 53 EGFR HER2 53 bioprosthetic valve 53 glomerular filtration rate 53 Lower Limb 53 NPM1 mutation 53 BMPR2 53 preoperative intraoperative 53 somatostatin analogs 53 TUNEL 53 histologically proven 53 BSIs 53 trough FEV1 53 8mg/kg 53 glycated hemoglobin HbA1c 53 virologic breakthrough 53 Ischaemic 53 osteopenic 53 SpO 2 53 dose pravastatin 53 Descriptive statistics 53 mucosal inflammation 53 UACR 53 Systemic Lupus Erythematosus 53 Logistic regression 53 Assessment Questionnaire 53 parasitaemia 53 Pain Rating Scale 53 electroencephalographic 53 clinically meaningful 53 MMSE score 53 procalcitonin 53 overt hypothyroidism 53 parasitemia 53 anemia hemoglobin 53 overt hepatic encephalopathy HE 53 CsA 53 cutaneous squamous cell carcinoma 53 HEDIS R 53 autonomic dysfunction 53 Thrombolysis 52 P = .# 52 SYNTAX 52 REMINYL ® 52 T1c 52 serum prostate 52 total cholesterol triglycerides 52 dose Iluvien 52 fluconazole resistant 52 Charlson Comorbidity Index 52 Alanine 52 ALA PDT 52 CYP#D# inhibitor 52 intrathoracic impedance 52 hypercalciuria 52 multivariable adjustment 52 symptomatology 52 Ishak fibrosis score 52 AUC0 52 Postoperatively 52 Interrater reliability 52 extrapyramidal symptoms 52 ertapenem 52 NATRECOR ® 52 vitreous haze 52 Serum concentrations 52 completely resected 52 8 OHdG 52 neutropenia thrombocytopenia 52 Adenomas 52 subclinical disease 52 lymphocytosis 52 leukocyte count 52 systolic function 52 serum uric acid sUA 52 ≥ 52 constipation predominant IBS 52 HOXB# 52 cardiac troponin 52 Genomic Grade 52 torsade de pointes 52 T2 lesions 52 Atopic Dermatitis 52 Breslow thickness 52 invasive carcinomas 52 poststroke 52 Sensitivity specificity 52 ß = 52 gastric carcinoma 52 HI titers 52 Stroke Scale NIHSS 52 CIBIC Plus 52 tirofiban 52 intestinal permeability 52 #mg/day [001] 52 ROC curves 52 atrophic gastritis 52 ACTEMRA TM 52 somatostatin analog 52 ipsilateral stroke 52 EMBLEM TM 52 Diabetic nephropathy 52 Pemetrexed 52 interobserver agreement 52 teriflunomide 52 transaminase elevations 52 oxycodone CR 52 belimumab 52 colorectal carcinoma 52 stratify patients 52 serum lipid levels 52 Oncotype 52 E selectin 52 spirometric 52 pulmonary capillary wedge 52 dose cytarabine 52 SLE Responder Index 52 ELISPOT 52 sweat chloride 52 glaucomatous 52 echogenicity 52 Hb A1c 52 adalimumab 52 fluticasone salmeterol 52 serum biomarker 52 genital ulcer 52 LPS induced 52 MTT assay 52 extraocular 52 Immunomodulatory 52 leukocyte adhesion 52 preintervention 52 debulking surgery 52 definite stent thrombosis 52 Nesiritide 52 OGTT 52 Angiographic 52 hemodynamic variables 52 differential gene expression 52 multivariate regression 52 CD# expression [002] 52 Coronary artery bypass grafting 52 epithelial tumors 52 fatigue diarrhea nausea